✦ LIBER ✦

Interleukin-7, interleukin-12, and GM-CSF gene transfer in patients with metastatic melanoma

✍ Scribed by D. Schadendorf; B. M. Czarnetzki; B. Wittig

Book ID: 104661594
Publisher: Springer
Year: 1995
Tongue: English
Weight: 441 KB
Volume: 73
Category: Article
ISSN: 0946-2716
DOI: 10.1007/bf00202266

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo electroporation-mediated transfe

In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice

✍ Iwai, M; Tahara, H; Imanishi, J; Mazda, O; Kishida, T; Asada, H; Satoh, E; Tanak 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 872 KB

Increased expression of perforin and gra

Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2

✍ Marie-Bénédicte Leger-Ravet; Claire Mathiot; Alain Portier; Maud Brandely; Pierr 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 792 KB

Evaluation of interleukin-2 administered

Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma

✍ Sewa S. Legha; Mary Ann Gianan; Carl Plager; Omar E. Eton; Nicholas E. J. Papado 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

## BACKGROUND. Interleukin-2 (IL-2) has been used widely in the treatment of advanced melanoma, most often using a high dose bolus schedule of administration. We have evaluated the antitumor activity and toxicity of IL-2 when administered by a continuous infusion schedule in patients with metastat

The hematologic toxicity of interleukin-

The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma

✍ Mark P. Macfarlane; James C. Yang; Anshu S. Guleria; Richard L White Jr.; Claudi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

Treatment with tumour infiltrating lymph

Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: A pilot study

✍ Johanna W. Baars; Johanna C. M. Fonk; Riekeld J. Scheper; B. Mary E. Blomberg-va 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 931 KB

Phase I trial of subcutaneous recombinan

Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma

✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou